Lymphoma in Australia statistics
The following material has been sourced from the Australian Institute of Health and Welfare
Lymphoma incorporates ICD-10 cancer codes C81 (Hodgkin lymphoma), C82 (Follicular lymphoma), C83 (Non-follicular lymphoma), C84 (Mature T/NK-cell lymphomas) and C85 (other and unspecified types of non-Hodgkin lymphoma) and C86 (other specified types of T/NK-cell lymphoma).
Estimated number of new cases of lymphoma diagnosed in 2021
7,207 = 4,136 males + 3,071 females
Estimated % of all new cancer cases diagnosed in 2021
4.8%
Estimated number of deaths from lymphoma in 2021
1,759 = 1,019 males + 740 females
Estimated % of all deaths from cancer in 2021
3.6%
Chance of surviving at least 5 years (2013–2017)
77%
People living with lymphoma at the end of 2016 (diagnosed in the 5 year period 2012 to 2016)
22,614
New cases
In 2017, when considered as a group Lymphomas were the 6th most commonly diagnosed cancer in Australia. It is estimated that they will remain the 6th most commonly diagnosed cancer in 2021.
In 2017, there were 6,317 new cases of lymphoma diagnosed in Australia (3,635 males and 2,682 females). In 2021, it is estimated that 7,207 new cases of lymphoma will be diagnosed in Australia (4,136 males and 3,071 females). In 2021, it is estimated that a person has a 1 in 41 (or 2.5%) risk of being diagnosed with lymphoma by the age of 85 (1 in 35 or 2.9% for males and 1 in 48 or 2.1% for females).
Figure 1. Estimated cancer incidence in Australia, 2021
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
- More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)
In 2017, the age-standardised incidence rate was 23 cases per 100,000 persons (27 for males and 18 for females). In 2021, it is estimated that the age-standardised incidence rate will remain at 23 cases per 100,000 persons (28 for males and 19 for females). The incidence rate for lymphoma is expected to increase with age, peaking at age group 85–89 years.
Figure 2. Age-standardised incidence rates for lymphoma, 1982 to 2017, by sex
Notes:
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
The number of new cases of lymphoma diagnosed increased from 1,918 (1,033 males and 885 females) in 1982 to 6,317 in 2016. Over the same period, the age-standardised incidence rate increased from 15 cases per 100,000 persons (17 for males and 13 for females) in 1982 to 23 cases per 100,000 in 2016.
Deaths
In 2019, when considered as a group, lymphomas were the 9th most common cause of cancer death in Australia. It is estimated that they will remain the 9th most common cause of death from cancer in 2021.
In 2019, there were 1,680 deaths from lymphoma in Australia (963 males and 717 females). In 2021, it is estimated that there will be 1,759 deaths (1,019 males and 740 females). In 2021, it is estimated that a person has a 1 in 181 (or 0.55%) risk of dying from lymphoma by the age of 85 (1 in 151 or 0.66% for males and 1 in 226 or 0.44% for females).
Figure 3. Estimated cancer mortality in Australia, 2021
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
- More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)
In 2019, the age-standardised mortality rate was 5.3 deaths per 100,000 persons (6.8 for males and 4.1 for females). In 2021, it is estimated that the age-standardised mortality rate will remain at 5.3 deaths per 100,000 persons (6.8 for males and 4.0 for females). The mortality rate for lymphoma is expected to increase with age.
Figure 4. Age-standardised mortality rates for lymphoma, 1982 to 2019, by sex
Notes:
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
The number of deaths from lymphoma increased from 918 (509 males and 409 females) in 1982 to 1,680 in 2019. Over the same period, the age-standardised mortality rate decreased from 7.4 deaths per 100,000 persons (9.1 for males and 6.0 for females) in 1982 to 5.3 deaths per 100,000 in 2019.
Survival
In 2013–2017, individuals diagnosed with lymphoma had a 77 % chance (76% for males and 79% for females) of surviving for five years compared to their counterparts in the general Australian population. Between 1988–1992 and 2013–2017, five-year relative survival for lymphoma improved from 54% to 77%.
Figure 5. 5-year relative survival for lymphoma, 1988–1992 to 2013–2017, by sex
Notes:
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
Prevalence
At the end of 2016, there were 5,462 people living who had been diagnosed with lymphoma that year, 22,614 people living who had been diagnosed with lymphoma in the previous 5 years (from 2012 to 2016) and 60,420 people living who had been diagnosed with lymphoma in the previous 35 years (from 1982 to 2016).
For more information on cancer data, see the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.